The Mark Hughes Foundation funded Brain Cancer Biobank which forms part of the Hunter Cancer Biobank (HCB) and works in collaboration with Brain Cancer Biobanking Australia currently have 4 research projects utilising samples generous provided by patients.

Currently four research projects are working with the samples from the biobank: 
1. Dr. James Lynam study on predicting clinical toxicity in GBM patients.
2. An observational clinical trial. EphA2 as a circulating biomarker for GBM progression.
3. A Quality Assurance Project: Glioblastoma circulating tumour cell isolation and detection
4. Whole exome sequencing of DNA to reveal the genetics of brain tumour development